Polatuzumab vedotin, sold under the brand name Polivy, is a CD79b-directed antibody-drug conjugate medication used for the treatment of diffuse large...
19 KB (1,315 words) - 04:49, 1 October 2024
Monomethyl auristatin E (redirect from Vedotin)
tisotumab vedotin Examples: Sofituzumab vedotin Polatuzumab vedotin (RG7596) Enfortumab vedotin Pinatuzumab vedotin Lifastuzumab vedotin Brentuximab vedotin Glembatumumab...
9 KB (649 words) - 22:01, 12 August 2023
influenza A and influenza B. Developed by Shionogi. 2019: Polivy (Polatuzumab vedotin-piiq): Treatment of diffuse large B-cell lymphoma when used in combination...
32 KB (2,865 words) - 04:21, 4 October 2024
Perjeta (pertuzumab), for HER-2 positive breast cancer. Polatuzumab vedotin|Polivy (polatuzumab vedotin), for diffuse large B-cell lymphoma. Protropin (somatrem)...
57 KB (5,180 words) - 21:47, 26 September 2024
Necitumumab Nivolumab Olaratumab Oportuzumab monatox Pembrolizumab Polatuzumab vedotin Prolgolimab Ramucirumab Retifanlimab Sabatolimab Sacituzumab govitecan...
12 KB (821 words) - 02:57, 12 October 2024
withdraw it. It was reintroduced into the US market in 2017. Brentuximab vedotin (trade name: Adcetris, marketed by Seattle Genetics and Millennium/Takeda)...
41 KB (4,305 words) - 11:56, 24 August 2024
doxorubicin, vincristine, and prednisone) plus rituximab. R-CHP with polatuzumab vedotin, an antibody-drug conjugate, was included as a category 1 preferred...
32 KB (3,190 words) - 06:53, 8 September 2024
on 11 August 2020. Retrieved 5 October 2020. "Padcev ejfv- enfortumab vedotin injection, powder, lyophilized, for solution". DailyMed. Archived from...
136 KB (4,079 words) - 00:12, 12 October 2024
September 2018 – CD22 Cemiplimab – Libtayo – September 2018 – PD-1 Polatuzumab vedotin – Polivy – June 2019 – CD79B The bispecific antibodies have arrived...
59 KB (4,170 words) - 01:29, 13 October 2024
L01FX11 Bermekimab L01FX12 Tafasitamab L01FX13 Enfortumab vedotin L01FX14 Polatuzumab vedotin L01FX15 Belantamab mafodotin L01FX16 Oportuzumab monatox...
12 KB (877 words) - 15:36, 25 January 2024
ABC variant often have mutations in the MYD88, CD79A and CD79B (polatuzumab vedotin) genes and overactive B-cell receptor, toll-like receptor, and NF-κB...
69 KB (8,143 words) - 18:36, 22 January 2024
Necitumumab Nivolumab Olaratumab Oportuzumab monatox Pembrolizumab Polatuzumab vedotin Prolgolimab Ramucirumab Retifanlimab Sabatolimab Sacituzumab govitecan...
12 KB (758 words) - 23:46, 14 March 2024
lymphocytic lymphoma Galcanezumab Eli Lilly episodic cluster headache Polatuzumab vedotin-piiq Genentech diffuse large B-cell lymphoma Pexidartinib Daiichi...
34 KB (180 words) - 17:05, 14 October 2024
Pinatuzumab vedotin§ Polatuzumab vedotin Rosmantuzumab Rovalpituzumab tesirine† Sacituzumab govitecan Sibrotuzumab§ Simtuzumab§ Sofituzumab vedotin§ Tacatuzumab...
3 KB (129 words) - 01:04, 19 July 2023
Pinatuzumab vedotin§ Polatuzumab vedotin Rosmantuzumab Rovalpituzumab tesirine† Sacituzumab govitecan Sibrotuzumab§ Simtuzumab§ Sofituzumab vedotin§ Tacatuzumab...
4 KB (241 words) - 13:42, 14 July 2024
Pinatuzumab vedotin§ Polatuzumab vedotin Rosmantuzumab Rovalpituzumab tesirine† Sacituzumab govitecan Sibrotuzumab§ Simtuzumab§ Sofituzumab vedotin§ Tacatuzumab...
5 KB (368 words) - 15:29, 21 August 2024